4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-000375
Chief Executive Officer sold 22,200 shares at an average $18.29 ($405,958)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2017-12-28 | Sale | −2,200 | $15.15 | $33,330 | 408,778 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2017-12-29 | Sale | −14,400 | $18.24 | $262,656 | 394,378 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2017-12-29 | Sale | −2,900 | $19.04 | $55,216 | 391,478 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2017-12-29 | Sale | −2,700 | $20.28 | $54,756 | 388,778 | I: show line 4 in the form |
| Open-market sales · 22,200 sh · avg $18.29 · $405,958 | |||||||
Loading xslF345X03/doc4.xml…